Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine
SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Undiagnosed sleep apnea is highly prevalent among hospital patients, and treating it after they're discharged can improve their chances of long-term survival, according to a ResMed-funded (NYSE: RMD, ASX: RMD) study published in theAmerican Journal of Medic...
ResMed Elects Karen Drexler to Its Board of Directors
A champion of women in leadership, Drexler brings wealth of experience at both commercial-stage and start-up medtech and healthcare companies Also at annual meeting of shareholders, long-serving Director Chris Roberts announced his retirement SAN DIEGO, Nov. 17, 2017 /PRNewswire/ -- ResMed (NYS...
Statement by ResMed on United Kingdom Case with Fisher & Paykel
SAN DIEGO, Nov. 13, 2017 /PRNewswire/ -- ResMed (NYSE: RMD, ASX: RMD) today
issued the following statement fromDavid Pendarvis, the company's global
general counsel and chief administrative officer:
Logo - https://mma.prnewswire.com/media/588826/RESMED_INC__LOGO.jpg
